Julia Freitas Orrico

Julia Freitas Orrico

Auto-generated profile, based on publicly available information

Julia Freitas Orrico

MicroGen DX, Orlando, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
NANilab Azim
Nilab Azim
JOJulia Freitas Orrico
Julia Freitas Orrico
DADivambal Appavoo
Divambal Appavoo
Lei ZhaiLei Zhai
Lei Zhai
SRSwaminathan Rajaraman
Swaminathan Rajaraman
3D printing involves the use of photopolymerizable resins, which are toxic and typically have incompatible properties with materials such as polystyrene (PS), which present limitations for biomedical applications. We present a method to dramatically improve the poor adhesion between the PS insulative layer on 3D printed Microelectrode Array (MEA) substrates by functionalizing the resin surface with polydopamine (PDA), a mussel-inspired surface chemistry derivative. A commercial 3D printing prepolymer resin, FormLabs Clear (FLC), was printed using a digital light processing (DLP) printer and then surface functionalized with PDA by alkali-induced aqueous immersion deposition and self-polymerization. It was observed that the adhesion of the PS to FLC was improved due to the precision emanating from the DLP method and further improved after the functionalization of DLP printed substrates with PDA at 1, 12, and 24 h time intervals. The adhesion of PS was evaluated through scotch tape peel testing and instron measurements of planar substrates and incubation testing with qualitative analysis of printed culture wells. The composition and topology of the samples were studied to understand how the properties of the surface change after PDA functionalization and how this contributes to the overall improvement in PS adhesion. Furthermore, the surface energies at each PDA deposition time were calculated from contact angle studies as it related to adhesion. Finally, biocompatibility assays of the newly modified surfaces were performed using mouse cardiac cells (HL-1) to demonstrate the biocompatibility of the PDA functionalization process. PDA surface functionalization of 3D DLP printed FLC resin resulted in a dramatic improvement of thin film PS adhesion and proved to be a biocompatible solution for improving additive manufacturing processes to realize biosensors such as in vitro MEAs.

1 March 2023 in Microsystems & Nanoengineering
Verified
Journal Article
Open access
PDF file
CDCharles Didier
Charles Didier
JOJulia F. Orrico
Julia F. Orrico
OTOmar S. Cepeda Torres
Omar S. Cepeda Torres
JCJorge Manrique Castro
Jorge Manrique Castro
AAliyah Baksh
Aliyah Baksh
SRSwaminathan Rajaraman
Swaminathan Rajaraman
Benchtop tissue cultures have become increasingly complex in recent years, as more on-a-chip biological technologies, such as microphysiological systems (MPS), are developed to incorporate cellular constructs that more accurately represent their respective biological systems. Such MPS have begun facilitating major breakthroughs in biological research and are poised to shape the field in the coming decades. These biological systems require integrated sensing modalities to procure complex, multiplexed datasets with unprecedented combinatorial biological detail. In this work, we expanded upon our polymer-metal biosensor approach by demonstrating a facile technology for compound biosensing that was characterized through custom modeling approaches. As reported herein, we developed a compound chip with 3D microelectrodes, 3D microfluidics, interdigitated electrodes (IDEs) and a microheater. The chip was subsequently tested using the electrical/electrochemical characterization of 3D microelectrodes with 1 kHz impedance and phase recordings and IDE-based high-frequency (~1 MHz frequencies) impedimetric analysis of differential localized temperature recordings, both of which were modeled through equivalent electrical circuits for process parameter extraction. Additionally, a simplified antibody-conjugation strategy was employed for a similar IDE-based analysis of the implications of a key analyte (l-glutamine) binding to the equivalent electrical circuit. Finally, acute microfluidic perfusion modeling was performed to demonstrate the ease of microfluidics integration into such a polymer-metal biosensor platform for potential complimentary localized chemical stimulation. Overall, our work demonstrates the design, development, and characterization of an accessibly designed polymer-metal compound biosensor for electrogenic cellular constructs to facilitate comprehensive MPS data collection.

2 September 2026 in Pilot and Feasibility Studies
Verified
Journal Article
Open access
PDF file
MKMariana Neri Lucas Kurihara
Mariana Neri Lucas Kurihara
ISIngrid Nayara Santos
Ingrid Nayara Santos
MSMayara Muniz de Andrade Silva
Mayara Muniz de Andrade Silva
LBLaura Batista
Laura Batista
CFCarlos Augusto Finelli
Carlos Augusto Finelli
MSMauro José Salles
Mauro José Salles
Background: Periprosthetic joint infection (PJI) remains difficult to diagnose due to the limited sensitivity of conventional culture, which frequently yields false-negative results. Targeted amplicon next-generation sequencing (tNGS) offers a method capable of identifying fastidious organisms, polymicrobial infections, and antimicrobial resistance genes. This pilot proof-of-concept study evaluated the feasibility of applying tNGS to sonicated fluid from orthopedic implants compared with conventional culture. Methods: Six sonicated fluid samples were collected from patients undergoing revision arthroplasty or removal of osteosynthesis devices between August and September 2024. Implants were processed in saline or Ringer’s lactate and subjected to a standardized sonication protocol, followed by aerobic and anaerobic culture. Parallel tNGS analysis targeted bacterial 16S rRNA and fungal internal transcribed spacer regions, sequenced on an Illumina MiSeq platform with bioinformatic quality control and contaminant filtering. Microbial identifications and predicted resistance genes were compared descriptively across methods. Results: Patients ranged in age from 23 to 76 years; comorbidities included diabetes, dyslipidemia, and hypertension. Conventional culture identified pathogens in four of six cases but missed fungi, several bacterial species, and resistance markers. In contrast, NGS successfully processed all six sonicated fluid samples, confirming the technical feasibility of the approach while confirming culture-positive organisms such as Staphylococcus aureus and detecting additional clinically relevant bacteria, fungi ( Cladosporium , Rhodotorula ), and resistance genes ( mecA , aph3′ ) that culture failed to identify. Two samples were negative by both methods. Discrepancies were more frequent in samples processed with Ringer’s lactate, suggesting interference with sequencing. Conclusions: This pilot study demonstrated the feasibility of applying targeted amplicon next-generation sequencing to sonicated fluid from orthopedic implants and highlighted its potential to complement conventional culture by identifying fastidious organisms, polymicrobial infections, and resistance determinants. These findings highlight its potential to improve diagnostic accuracy and guide personalized antimicrobial therapy in PJI. Although the small sample size and descriptive design limit generalizability, pilot study provides early evidence supporting the feasibility of applying tNGS to sonicated fluid and identifies methodological considerations for future research. Larger prospective trials are warranted to validate these results and establish NGS as an adjunct or alternative to culture in orthopedic infection diagnostics. Trial registration: The study protocol was approved by the local Institutional Review Board (CAAE: 46277421.1.0000.5479; approval number: 4.713.409).